Safety Profiles of Adalimumab, Etanercept and Infliximab: a Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events

AuthID
P-009-B08
3
Author(s)
Alves, C
·
Batel Marques, F
Tipo de Documento
Article
Year published
2014
Publicado
in JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, ISSN: 0269-4727
Volume: 39, Número: 3, Páginas: 307-313 (7)
Indexing
Publication Identifiers
Pubmed: 24635532
SCOPUS: 2-s2.0-84899437013
Wos: WOS:000334679600013
Source Identifiers
ISSN: 0269-4727
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.